Close Window

Digital Look Email A Friend

GW Pharmaceuticals tests epilepsy drug in man as FDA softens stance

Published on 18th September 2013

Cannabis-derived drug developer GW Pharmaceuticals has begun human trials of its epilepsy treatment.

URL: http://www.digitallook.com/dl/news/story/21164890/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.